Humankind Investments’s Exelixis EXEL Stock Holding History

Humankind Investments’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Hold	26,500	–	–	0.69%	18
2026 Q1	$1.14M	Buy	+26,500	New	+$1.14M	0.65%	18

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Humankind Investments's EXEL Position: Q2 2026 in Review

Humankind Investments held its Exelixis (EXEL) position steady in Q2 2026 at 26,500 shares worth $1.44M. The position accounts for 0.69% of the portfolio, ranked #18.

Humankind Investments first reported a position in EXEL in Q1 2026 and has held it in 2 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Humankind Investments held 26,500 shares of Exelixis worth $1.44M as of Q2 2026.
Humankind Investments left its Exelixis share count unchanged in Q2 2026.
Exelixis made up 0.69% of Humankind Investments's portfolio in Q2 2026, its #18 holding.
Humankind Investments first reported a position in Exelixis in Q1 2026 and has held it in 2 quarters since.
756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Humankind Investments's 13F filing for Q2 2026, filed 14 Aug 2026.